Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004)
Clinical trial NCT03873038 · COMPLETED
Trial details
- NCT number
- NCT03873038
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-29
- Primary completion
- 2021-12-20
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.